Teal background image.

Governor Hochul Announces Strides Pharma Inc. to Move Manufacturing Operations to Rockland County

Acquisition of Manufacturing facility from subsidiaries of Endo International plc ("Endo"), Retain and Create 250 Jobs in the Mid-Hudson Region 

Governor Kathy Hochul today announced that Strides Pharma Inc. will expand its manufacturing and marketing operations from New Jersey and Florida to Chestnut Ridge, Rockland County, New York. Strides will acquire and build out the former Endo Pharmaceutical plant, retain more than 215 of its employees, add an additional 40 jobs and invest more than $42 million over a span of the next few years to manufacture both brand-name and generic drugs for its own distribution and marketing as well as for others as a contract manufacturer.     

Strides Pharma Science Limited, the parent company of Strides Pharma, Inc., is a pharmaceutical company with a major focus on development and manufacture of technology-led finished dosage formulations. The company is also among the world's largest manufacturers of soft gelatin capsules.   

"The COVID-19 pandemic has made clear that having domestically produced medical supplies, especially in times of crisis, is critical for a secure supply chain and a safer New York," Governor Hochul said. "I am pleased that Strides Pharma, Inc. will expand in the Mid-Hudson region, creating good paying jobs and investing in the State's economy." 

Lieutenant Governor Brian Benjamin said, "This is another great company that has recognized that New York State is a good place to do business. Strides Pharma's move to acquire Endo Pharmaceuticals and invest in the region will fill a critical need for pharmaceuticals manufactured in the U.S, retain and create much needed jobs and continue the positive momentum we are experiencing as we move further from the hardships brought by the COVID-19 pandemic."  

Read the full press release here.